Invasive pneumococcal infections: a clinical and microbiological analysis of 53 patients in Taiwan

C-Y Lee1, C-H Chiu, Y-C Huang

  • 1Department of Pediatrics, Taoyuan General Hospital, Taoyuan, Taiwan, ROC.

Abstract

Insights

Penicillin resistance in Streptococcus pneumoniae is high, especially in children, linked to prior antibiotic use. Vaccination is recommended for high-risk groups to prevent invasive pneumococcal infections.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Public Health

Background:

  • Invasive pneumococcal infections (ISPI) pose a significant health burden.
  • Understanding antimicrobial susceptibility patterns is crucial for effective treatment.
  • Penicillin resistance in Streptococcus pneumoniae is a growing concern globally.

Purpose of the Study:

  • To determine penicillin susceptibility among Streptococcus pneumoniae causing invasive diseases.
  • To identify risk factors associated with antibiotic resistance in these infections.
  • To compare resistance patterns between pediatric and adult populations.

Main Methods:

  • Retrospective study of patients with invasive pneumococcal infections.
  • Microbiological confirmation and clinical data review.
  • Determination of Minimum Inhibitory Concentrations (MICs) for penicillin and ceftriaxone using NCCLS methodology.

Main Results:

  • High rates of penicillin-nonsusceptible Streptococcus pneumoniae (PNSP) were observed (95.5% in children, 54.8% in adults).
  • Penicillin-resistant Streptococcus pneumoniae (PRSP) rates were substantial (45.5% in children, 41.9% in adults).
  • Prior antibiotic use was more frequent in children, correlating with higher PNSP rates; adults had more underlying diseases and higher mortality.

Conclusions:

  • Urgent need for strategies to combat high penicillin resistance in Streptococcus pneumoniae.
  • Vaccination is recommended for young children and elderly individuals with underlying conditions to prevent ISPI.
  • Further research into resistance mechanisms and alternative treatment options is warranted.

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...